Show simple item record

dc.contributor.authorNewbury, Alex
dc.contributor.authorFerguson, Chantal M.
dc.contributor.authorValero, Daniel Alvarez
dc.contributor.authorKutcher-Diaz, Roberto
dc.contributor.authorMcIntosh, Lacey J.
dc.contributor.authorKaramanian, Ara
dc.contributor.authorHarman, Aaron
dc.date2022-08-11T08:10:50.000
dc.date.accessioned2022-08-23T17:21:57Z
dc.date.available2022-08-23T17:21:57Z
dc.date.issued2022-06-20
dc.date.submitted2022-07-15
dc.identifier.citation<p>Newbury A, Ferguson C, Valero DA, Kutcher-Diaz R, McIntosh L, Karamanian A, Harman A. Interventional oncology update. Eur J Radiol Open. 2022 Jun 20;9:100430. doi: 10.1016/j.ejro.2022.100430. PMID: 35761853; PMCID: PMC9233207. <a href="https://doi.org/10.1016/j.ejro.2022.100430">Link to article on publisher's site</a></p>
dc.identifier.issn2352-0477 (Linking)
dc.identifier.doi10.1016/j.ejro.2022.100430
dc.identifier.pmid35761853
dc.identifier.urihttp://hdl.handle.net/20.500.14038/48640
dc.description.abstractInterventional Oncology (IO) is a subspecialty field of Interventional Radiology bridging between diagnostic radiology and the clinical oncology team, addressing the diagnosis and treatment of cancer. There have been many exciting advancements in the field of IO in recent years; far too many to cover in a single paper. To give each topic sufficient attention, we have limited the scope of this review article to four topics which we feel have the potential to drastically change how cancer is treated managed in the immediate future.
dc.language.isoen_US
dc.relation<p><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=35761853&dopt=Abstract">Link to Article in PubMed</a></p>
dc.rightsPublished by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectArtificial intelligence
dc.subjectBreast ablation
dc.subjectImmune checkpoint inhibitors
dc.subjectInterventional oncology
dc.subjectProstate ablation
dc.subjectNeoplasms
dc.subjectOncology
dc.subjectRadiology
dc.titleInterventional oncology update
dc.typeArticle
dc.source.journaltitleEuropean journal of radiology open
dc.source.volume9
dc.identifier.legacyfulltexthttps://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=1720&amp;context=radiology_pubs&amp;unstamped=1
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/radiology_pubs/703
dc.identifier.contextkey30234291
refterms.dateFOA2022-08-23T17:21:57Z
html.description.abstract<p>Interventional Oncology (IO) is a subspecialty field of Interventional Radiology bridging between diagnostic radiology and the clinical oncology team, addressing the diagnosis and treatment of cancer. There have been many exciting advancements in the field of IO in recent years; far too many to cover in a single paper. To give each topic sufficient attention, we have limited the scope of this review article to four topics which we feel have the potential to drastically change how cancer is treated managed in the immediate future.</p>
dc.identifier.submissionpathradiology_pubs/703
dc.contributor.departmentDepartment of Radiology
dc.source.pages100430


Files in this item

Thumbnail
Name:
Publisher version
Thumbnail
Name:
123.pdf
Size:
3.807Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Except where otherwise noted, this item's license is described as Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).